Insider Trading & Ownership of David M. Rubenstein

Location
Washington, DC
Summary
The estimated net worth of David M. Rubenstein is at least $1,279,149,088 dollars as of 20 Mar 2026. David M. Rubenstein is the Director of Carlyle Group Inc. and owns shares of Carlyle Group Inc. (CG) stock worth about $1.28B. David M. Rubenstein is the Director of Moderna, Inc. and owns shares of Moderna, Inc. (MRNA) stock worth about $133.7K.
Signature
/s/ Anne K. Frederick by power of attorney for David M. Rubenstein
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow David M. Rubenstein and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • David M. Rubenstein has 2 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,279,149,088.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: Carlyle Group Inc. ($1,279,015,381).
  • Past-year value change for that position: -$58,683,750.

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of David M. Rubenstein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CG, CGABL Carlyle Group Inc. Director $1,279,015,381 -$58,683,750 -4.4% 19 Mar 2026
MRNA Moderna, Inc. Director $133,707 05 Aug 2025

Insider Transactions Reported by David M. Rubenstein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored